PLI.TO: Summary for PROMETIC LIFE SCIENCES INC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:05am EST - Canadian Markets open in 5 hours and 25 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

PROMETIC LIFE SCIENCES INC (PLI.TO)

On Feb 9: 0.18 CAD 0.00 (0.00%)

MORE ON PLI.TO

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

PROMETIC LIFE SCIENCES INC (Toronto:PLI.TO) Delayed quote data

Last Trade:	0.18 CAD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.18
Open:	0.17
Bid:	0.175
Ask:	0.18
1y Target Est:	N/A

Day's Range:	0.17 - 0.18
52wk Range:	0.11 - 0.24
Volume:	214,450
Avg Vol (3m):	299,052
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add PLI.TO to Portfolio

Download Data

HEADLINES

•	ProMetic Life Sciences Inc./VCJD Infection: A Continuing Threat to Public Health
	Marketwire (Thu, Feb 4)

•	Novozymes and ProMetic Enter Into Alliance for Purification of Albumin-Fusion Proteins
	Marketwire (Tue, Feb 2)

•	ProMetic Life Sciences Inc.: Prion Filtration May Become a Legal Requirement for All Blood Transfused in the UK
	Marketwire (Mon, Jan 25)

•	Summary of ProMetic's Presentation at Biotech Showcase 2010
	Marketwire (Tue, Jan 12)

•	ProMetic to Present at Biotech Showcase 2010
	Marketwire (Thu, Jan 7)

•	ProMetic Announces Agreement to Commercialize Prion Capture Technology
	Marketwire (Tue, Jan 5)

•	ProMetic Validates Its Regulatory Pathway for PBI-1402 With the FDA
	Marketwire (Fri, Dec 11)

•	ProMetic Life Sciences to develop product process for unnamed multinational
	The Canadian Press (Tue, Dec 1)

•	ProMetic Enters Agreement to Improve Manufacturing Process for Second-Generation Biopharmaceutical Targeting $1B Market
	Marketwire (Tue, Dec 1)

•	SaBTO Recommends Use of P-Capt(R) Prion Reduction Filter to Protect Children From vCJD Blood Transmission
	Marketwire (Fri, Nov 20)

More Headlines for PLI.TO...

BUSINESS SUMMARY

No business summary available for PLI.TO.

Add to Portfolio

Email to a Friend

•